ACT CAPITAL MANAGEMENT, LLC - Q2 2019 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2019
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO6Q3 202222.7%
ARROWHEAD PHARMACEUTICALS INC6Q3 202210.1%
ARCTURUS THERAPEUTICS HLDGS6Q3 202212.8%
CLEARSIDE BIOMEDICAL INC6Q3 20227.7%
KRYSTAL BIOTECH INC6Q3 20225.6%
FUBOTV INC6Q3 20224.4%
EIGER BIOPHARMACEUTICALS INC6Q3 20222.4%
ASPIRA WOMENS HEALTH INC6Q3 20223.3%
ICAD INC6Q3 20222.0%
INHIBIKASE THERAPEUTICS INC COM6Q3 20221.7%

View ACT CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ACT CAPITAL MANAGEMENT, LLC Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HyreCar Inc.December 09, 2020230,0001.3%
SOLIGENIX, INC.February 07, 20201,221,4995.6%
EDISON NATION, INC.April 18, 2019214,4543.8%
Hancock Jaffe Laboratories, Inc.December 26, 2018503,5004.3%
Ampio Pharmaceuticals, Inc.August 10, 20181,210,7851.4%
Xspand Products Lab, Inc.May 09, 2018405,0009.3%
CROSSROADS SYSTEMS INCJune 16, 201759,0534.8%
ALLDIGITAL HOLDINGS, INC.Sold outJanuary 23, 201700.0%
MOBIVITY HOLDINGS CORP.January 06, 20171,734,9164.8%
Akers Biosciences IncJanuary 25, 2016213,5003.9%

View ACT CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2022-11-03
13F-HR2022-08-12
13F-HR2022-05-11
13F-HR2022-02-03
13F-HR2021-11-16
13F-HR2021-08-16
SC 13G/A2020-12-09
SC 13G/A2020-02-10
SC 13G/A2020-02-07
SC 13G/A2020-02-07

View ACT CAPITAL MANAGEMENT, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export ACT CAPITAL MANAGEMENT, LLC's holdings

CSVXLS